Navigation Links
CHMP Recommends Approval in the European Union (EU) for New Options for Patients With Certain Primary Brain Tumors
Date:12/8/2008

concomitant TEMODAR and radiotherapy for the 42-day regimen. There may be a higher occurrence of PCP when temozolomide is administered during a longer dosing regimen. However, all patients receiving temozolomide, particularly patients receiving steroids, should be observed closely for the development of PCP regardless of the regimen.

Caution should be exercised when administered to those with severe hepatic or renal impairment.

TEMODAR Capsules should not be opened or chewed. If capsules are accidentally opened or damaged, rigorous precautions should be taken with the capsule contents to avoid inhalation or contact with the skin or mucous membranes.

The effectiveness of TEMODAR in children has not been established.

In newly diagnosed patients with GBM, the adverse event profile was similar in patients <65 years of age and those greater than or equal to 65 years.

In newly diagnosed GBM, the most common adverse events in clinical

studies in the Concomitant Phase (Radiotherapy + TEMODAR) and the Maintenance Phase (TEMODAR alone), respectively, were alopecia 69%, 55%; fatigue 54%, 61%; nausea 36%, 49%; vomiting 20%, 29%; anorexia 19%, 27%; headache 19%, 23%; constipation 18%, 22%; with the following important adverse events also reported: convulsions 6%, 11% and thrombocytopenia 4%; 8%.

Of these adverse events, those grade greater than or equal to 3 in clinical studies in the Concomitant Phase (Radiotherapy + TEMODAR) and the Maintenance Phase (TEMODAR alone), respectively, were fatigue 7%, 9% nausea; 1%, 1%; vomiting <1%, 2%; anorexia 1%, 1%; headache 2%, 4%; constipation 1%, 0%; convulsions 3%, 3%; thrombocytopenia 3%, 4%.

In the newly diagnosed GBM population, when laboratory abnormalities and adverse events were combined, Grade 3 or 4 neutropenia occurred in 8% and Grade 3 or 4 platelet abnormalities i
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. CHMP Recommends Expanded Use of Angiox(R) (Bivalirudin) in Europe for Patients With Acute Coronary Syndromes
2. Independent Data Safety Monitoring Board Recommends Continuation of Sangarts Pivotal Phase III Trials of Hemospan(R) Following Second Interim Review
3. FDA Advisory Committee Unanimously Recommends U.S. Approval of Sugammadex, the First and Only Selective Relaxant Binding Agent
4. FDA Advisory Committee Unanimously Recommends Approval of Ustekinumab for Treatment of Moderate to Severe Plaque Psoriasis
5. Task Force Recommends Screening for Hearing Loss in All Newborns
6. CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients
7. Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout
8. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
9. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
10. CryoCor Receives FDA Approval for Right Atrial Flutter
11. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... -- Anpac Bio-Medical Science Co., Ltd., Chief Executive Officer and ... research team are introducing what the 2015 Nobel Prize ... "game changing" and "breakthrough" early cancer detection technology research ... Annual Meeting in Chicago, Illinois , ... An accomplished inventor with over 200 patent applications (100 ...
(Date:5/29/2015)... , May 29, 2015  Fair Rate Funding, ... a state-court jury in Delaware ... inserts, designed to treat pelvic organ prolapse (POP) and ... and that company executives hid the design flaws from ... - http://photos.prnewswire.com/prnh/20150529/219354LOGO Transvaginal mesh, ...
(Date:5/29/2015)... May 29, 2015 Actinobac Biomed, NovoPedics, Inc. ... with investments from Foundation Venture Capital Group (FVCG), have ... 2015 as part of the Start-Up Stadium and Company ... James M. Golubieski . The ... will be held in Philadelphia ...
Breaking Medicine Technology:Anpac Bio-Medical Introduces 'Game Changing' Cancer Screening Tech at American Society of Clinical Oncology Meeting - Chicago 5/29 - 6/2 2Anpac Bio-Medical Introduces 'Game Changing' Cancer Screening Tech at American Society of Clinical Oncology Meeting - Chicago 5/29 - 6/2 3TV Mesh Lawsuit Funding Firm, Fair Rate Funding, Reports Delaware Woman Awarded $100 Million Against Boston Scientific in Pelvic Mesh Verdict. 2TV Mesh Lawsuit Funding Firm, Fair Rate Funding, Reports Delaware Woman Awarded $100 Million Against Boston Scientific in Pelvic Mesh Verdict. 3Foundation Venture Capital Group Portfolio Companies to be Highlighted at Bio International in June 2Foundation Venture Capital Group Portfolio Companies to be Highlighted at Bio International in June 3
... Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) ... September 30, 2011. "We are focused on ... complete response letter around year-end and filing the lorcaserin ... the first half of next year," stated Jack Lief, ...
... China Kanghui Holdings (NYSE: KH ) ("Kanghui" or ... orthopedic implants in China, today announced financial results for the ... Highlights Total net revenue for the third ... from RMB63.6 million in the corresponding period of ...
Cached Medicine Technology:Arena Pharmaceuticals Announces Third Quarter 2011 Financial Results 2Arena Pharmaceuticals Announces Third Quarter 2011 Financial Results 3Arena Pharmaceuticals Announces Third Quarter 2011 Financial Results 4Arena Pharmaceuticals Announces Third Quarter 2011 Financial Results 5Arena Pharmaceuticals Announces Third Quarter 2011 Financial Results 6Arena Pharmaceuticals Announces Third Quarter 2011 Financial Results 7Arena Pharmaceuticals Announces Third Quarter 2011 Financial Results 8China Kanghui Holdings Reports Third Quarter 2011 Financial Results 2China Kanghui Holdings Reports Third Quarter 2011 Financial Results 3China Kanghui Holdings Reports Third Quarter 2011 Financial Results 4China Kanghui Holdings Reports Third Quarter 2011 Financial Results 5China Kanghui Holdings Reports Third Quarter 2011 Financial Results 6China Kanghui Holdings Reports Third Quarter 2011 Financial Results 7China Kanghui Holdings Reports Third Quarter 2011 Financial Results 8China Kanghui Holdings Reports Third Quarter 2011 Financial Results 9China Kanghui Holdings Reports Third Quarter 2011 Financial Results 10China Kanghui Holdings Reports Third Quarter 2011 Financial Results 11China Kanghui Holdings Reports Third Quarter 2011 Financial Results 12China Kanghui Holdings Reports Third Quarter 2011 Financial Results 13China Kanghui Holdings Reports Third Quarter 2011 Financial Results 14
(Date:5/30/2015)... Houston, Texas (PRWEB) May 30, 2015 ... week for 2015’s Aesthetic Meeting, sponsored by the American ... many industry vendors on hand was Zeltiq, the parent ... the aesthetic space, CoolSculpting. With blazing growth, the ... , Zeltiq is currently in the ...
(Date:5/30/2015)... On Thursday, May 14, the Mesothelioma ... Dr. Evan Alley both of the University of ... series. The interview was part of the series ... Drs. Simone and Alley were interviewed by the ... they discussed the mesothelioma program at the University ...
(Date:5/30/2015)... City of Industry, CA (PRWEB) May 30, 2015 ... of best-in-class technology and foreign travelers who experienced OGAWA ... made available in the U.S. , A leader ... decades, OGAWA is a cutting-edge designer, researcher, developer and ... for the longevity and superior craftsmanship of their products, ...
(Date:5/30/2015)... May 30, 2015 Cyclist Barry ... “Wheels for the World 2015: Piles of Miles” ... raise awareness about hemophilia and encourage individuals to ... , Save One Life supports nearly 1,200 ... developing countries through direct sponsorships, scholarships and micro-enterprise ...
(Date:5/30/2015)... The iconic American actor, and host of “In ... segment on Medical Malpractice. This segment of “In America” ... health care field. , According to the Bureau of ... were filed, roughly only 20% of them made it ... while the remaining 30% were tossed out. (Source: ...
Breaking Medicine News(10 mins):Health News:Dr. Paul Vitenas Meets with Zeltiq President and CEO in Montreal 2Health News:Dr. Paul Vitenas Meets with Zeltiq President and CEO in Montreal 3Health News:Interview with Mesothelioma Experts, Drs. Simone and Alley Now Available on Demand 2Health News:Award-winning OGAWA Massage Chairs Finally Available for purchase in North America. 2Health News:Award-winning OGAWA Massage Chairs Finally Available for purchase in North America. 3Health News:Barry Haarde Cycles 4,000 Miles Across the USA for Hemophilia 2
... central hypoventilation syndrome (CCHS) may suffer brain damage// if ... Central Hypoventilation Syndrome is the absence of appropriate trigger ... from CCHS may not breathe regularly during sleep, or ... to breathe during wakeful hours but may not be ...
... Researchers have been able to unearth the gene responsible ... responsible for behaving according to a norm in the ... National Institute of Mental Health (NIMH) have been able ... behavior in people. Researchers results came as they were ...
... is being published showing the benefits of omega-3 fatty acids.// ... to the aftertaste/burp-back associated with fish oil. , ,Researchers ... fish oil capsule that makes taking omega-3s both easy and ... formulation with a soft chewable shell that can be taken ...
... has been known to help in the brain development of ... this reason it is administered to pregnant women. A new ... that this vitamin can slow down the cognitive decline in ... 818 subjects (both men and women) with increased levels of ...
... stop the geriatric population from falling and hurting themselves from ... called Yaktrax Walker. This is plastic netting like structure that ... in maintaining a stable walk that will prevent falls. ... maintain a diary of the number of falls they have ...
... to their departed loved one's DNA// through a new profile ... service is being offered by a New Jersey-based firm called ... useful for medical, legal and genealogy issues as well as ... range of information such as protection against future estate or ...
Cached Medicine News:
... traditional Lasik, Epi-Lasik and anterior and posterior ... changing technologies and applications in refractive and ... a proven value, offering surgeons a platform ... them to stay abreast of evolving technologies ...
Versatility of the DFS Standard Fixator provides unsurpassed below-the-ring correction of angular, rotational and translational deformities. Length discrepancy can be precisely corrected in 1/4mm inc...
The PreFix™ temporary fixator prepares you for any situation that requires rapid stabilization of complex fractures....
Angulation, translation and rotation. A whole different point of view. The Sheffield Ring Fixation System is a design achievement that advances the possibilities of fracture management....
Medicine Products: